Topics
More on Mergers & Acquisitions

Memorial Hermann to purchase Memorial Hermann Northeast Hospital

Board of 11 community members appointed by City Council has served as the governing body for over 30 years.

Jeff Lagasse, Associate Editor

Memorial Hermann Health System has reached a deal to purchase the Memorial Hermann Northeast Hospital campus, located in Humble, Texas, from the Northeast Hospital Authority Board of Trustees, the hospitals jointly announced. Financial terms of the deal were not disclosed.

A board of 11 community members appointed by the Humble City Council has served as the governing body of the Northeast Hospital Authority Hospital since 1977.

The transaction comes on the heels of the announced plans to build a 45,000-square-foot Memorial Hermann Convenient Care Center in Kingwood. The center will be anchored by Memorial Hermann Northeast and will join the Summer Creek Convenient Care Center in serving the greater Lake Houston area.

[Also: Time-lapse video shows how Memorial Hermann's $85 million hospital expansion unfolded]

With the purchase finalized, Memorial Hermann plans to construct a new 123,000-square foot patient tower with 90 updated patient rooms, and the flexibility to add an additional 30 inpatient beds as needed. The new patient tower will also house patient and staff dining services.

The patient rooms in the new tower will replace those currently located in the hospital's South Tower, and will be nearly twice the size of current rooms. Construction of the tower will be accompanied by additional surface parking, as well as renovations to the east entrance to the hospital.

Memorial Hermann Northeast has been recognized by the Joint Commission, an accreditor of U.S. healthcare organizations, as a top performer on key quality measures. The hospital offers interventional cardiology, oncology, spine surgery, orthopedics and sports medicine and endovascular surgery.

In the last year, the hospital has opened a Clinical Decision Unit to maximize efficiency in treatment and diagnosis, and an endovascular hybrid suite designed specifically for vascular and cardiovascular patients.

Twitter: @JELagasse

Show All Comments